VSee Health, Inc. Net Change in Cash
VSee Health, Inc. (VSEE) reported Net Change in Cash of -$4.60 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2026-08-14
- VSee Health, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2026-03-31 was -$3.92M, a 4766.46% decline year-over-year.
- VSee Health, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2025-03-31 was $84.01K, a 85.28% decline year-over-year.
- VSee Health, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was $570.55K.
- VSee Health, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was -$90.67K.
- VSee Health, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2025 was $4.94M, a 2282.17% increase from fiscal 2024.
- VSee Health, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2024 was $207.38K.
- VSee Health, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was -$111.93K.
- VSee Health, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$653.01K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 4 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 7 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$4.60M 10-Q · filed 2026-08-14 | |||||||||
| 2026-03-31 | -$3.92M 10-Q · filed 2026-05-15 | |||||||||
| 2025-12-31 | $4.94M 10-K · filed 2026-03-31 | |||||||||
| 2025-09-30 | $146.64K 10-Q · filed 2025-11-14 | |||||||||
| 2025-06-30 | -$34.52K 10-Q · filed 2026-08-14 | |||||||||
| 2025-03-31 | $84.01K 10-Q · filed 2026-05-15 | |||||||||
| 2024-12-31 | $207.38K 10-K · filed 2026-03-31 | |||||||||
| 2024-09-30 | $2.21M 10-Q · filed 2025-11-14 | |||||||||
| 2024-06-30 | $987.24K 10-Q/A · filed 2025-11-20 | |||||||||
| 2024-03-31 | $570.55K 10-Q · filed 2025-10-15 | -$1.14K 10-Q · filed 2024-05-15 | ||||||||
| 2023-12-31 | -$111.93K 10-K/A · filed 2025-08-29 | -$105.14K 10-K · filed 2024-04-12 | ||||||||
| 2023-09-30 | -$71.13K 10-Q · filed 2024-11-14 | -$106.49K 10-Q · filed 2023-11-20 | ||||||||
| 2023-06-30 | -$157.33K 10-Q · filed 2024-09-23 | -$76.14K 10-Q · filed 2023-08-21 | ||||||||
| 2023-03-31 | -$90.67K 10-Q · filed 2024-05-15 | |||||||||
| 2022-12-31 | -$653.01K 10-K · filed 2024-04-12 | |||||||||
| 2022-09-30 | -$715.04K 10-Q · filed 2023-11-20 | |||||||||
| 2022-06-30 | -$568.89K 10-Q · filed 2023-08-21 | |||||||||
| 2022-03-31 | -$250.29K 10-Q · filed 2023-05-15 | |||||||||
| 2021-12-31 | $760.01K 10-K · filed 2023-04-12 | |||||||||
| 2021-09-30 | $5.50K 10-Q · filed 2022-11-10 | |||||||||
| 2021-06-30 | $77.11K 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Agape ATP Corp (ATPC) | $0.002B | ||
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |